ATE213951T1 - Cyclosporin enthaltende, biologisch aktive zubereitung - Google Patents

Cyclosporin enthaltende, biologisch aktive zubereitung

Info

Publication number
ATE213951T1
ATE213951T1 AT96923154T AT96923154T ATE213951T1 AT E213951 T1 ATE213951 T1 AT E213951T1 AT 96923154 T AT96923154 T AT 96923154T AT 96923154 T AT96923154 T AT 96923154T AT E213951 T1 ATE213951 T1 AT E213951T1
Authority
AT
Austria
Prior art keywords
biologically active
phase
preparation containing
cyclosporine
active preparation
Prior art date
Application number
AT96923154T
Other languages
English (en)
Inventor
Kare Larsson
Helena Ljusberg-Wahren
Original Assignee
Camurus Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Camurus Ab filed Critical Camurus Ab
Application granted granted Critical
Publication of ATE213951T1 publication Critical patent/ATE213951T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases, cochleates; Sponge phases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Transplantation (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
AT96923154T 1995-07-06 1996-07-02 Cyclosporin enthaltende, biologisch aktive zubereitung ATE213951T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9502472A SE504582C2 (sv) 1995-07-06 1995-07-06 Cyklosporinkomposition baserad på en L2-fas
PCT/SE1996/000893 WO1997002042A1 (en) 1995-07-06 1996-07-02 Biologically active composition comprising cyclosporine

Publications (1)

Publication Number Publication Date
ATE213951T1 true ATE213951T1 (de) 2002-03-15

Family

ID=20398887

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96923154T ATE213951T1 (de) 1995-07-06 1996-07-02 Cyclosporin enthaltende, biologisch aktive zubereitung

Country Status (12)

Country Link
EP (1) EP0873133B1 (de)
JP (1) JPH11508592A (de)
AT (1) ATE213951T1 (de)
AU (1) AU6374596A (de)
BR (1) BR9609332A (de)
CA (1) CA2226219A1 (de)
CZ (1) CZ1998A3 (de)
DE (2) DE69619700T2 (de)
ES (1) ES2123477T3 (de)
NO (1) NO980032L (de)
SE (1) SE504582C2 (de)
WO (1) WO1997002042A1 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE511313C2 (sv) 1997-01-13 1999-09-06 Gs Dev Ab Komposition med reglerad frisättning innefattande fettsyraester av diacylglycerol
CA2313024C (en) 1997-12-10 2008-06-03 Severson, Mary L. Pharmaceutical compositions containing an omega-3 fatty acid oil
PL348193A1 (en) * 1998-12-11 2002-05-06 Pharmasolutions Self-emulsifying compositions for drugs poorly soluble in water
CA2508907A1 (en) 2001-11-08 2003-05-15 Atrium Medical Corporation Intraluminal device with a coating containing a therapeutic agent
US8263102B2 (en) 2004-09-28 2012-09-11 Atrium Medical Corporation Drug delivery coating for use with a stent
US9801913B2 (en) 2004-09-28 2017-10-31 Atrium Medical Corporation Barrier layer
US9801982B2 (en) 2004-09-28 2017-10-31 Atrium Medical Corporation Implantable barrier device
US8312836B2 (en) 2004-09-28 2012-11-20 Atrium Medical Corporation Method and apparatus for application of a fresh coating on a medical device
US8367099B2 (en) 2004-09-28 2013-02-05 Atrium Medical Corporation Perforated fatty acid films
US9000040B2 (en) 2004-09-28 2015-04-07 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
US9012506B2 (en) 2004-09-28 2015-04-21 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
US9427423B2 (en) 2009-03-10 2016-08-30 Atrium Medical Corporation Fatty-acid based particles
US9278161B2 (en) 2005-09-28 2016-03-08 Atrium Medical Corporation Tissue-separating fatty acid adhesion barrier
CA2626030A1 (en) 2005-10-15 2007-04-26 Atrium Medical Corporation Hydrophobic cross-linked gels for bioabsorbable drug carrier coatings
US9492596B2 (en) 2006-11-06 2016-11-15 Atrium Medical Corporation Barrier layer with underlying medical device and one or more reinforcing support structures
WO2008057344A2 (en) 2006-11-06 2008-05-15 Atrium Medical Corporation Coated surgical mesh
WO2008122967A2 (en) 2007-04-04 2008-10-16 Sigmoid Pharma Limited An oral pharmaceutical composition
US9278070B2 (en) 2009-05-18 2016-03-08 Sigmoid Pharma Limited Composition comprising oil drops
US20110038910A1 (en) 2009-08-11 2011-02-17 Atrium Medical Corporation Anti-infective antimicrobial-containing biomaterials
EP2464341B1 (de) 2009-08-12 2022-07-06 Sublimity Therapeutics Limited Immunmodulatorische zusammensetzungen mit einer polymermatrix und einer ölphase
WO2012009707A2 (en) 2010-07-16 2012-01-19 Atrium Medical Corporation Composition and methods for altering the rate of hydrolysis of cured oil-based materials
GB201020032D0 (en) 2010-11-25 2011-01-12 Sigmoid Pharma Ltd Composition
JO3337B1 (ar) * 2010-12-13 2019-03-13 Debiopharm Sa تركيبات صيدلية تشمل أليسبوريفير
US9867880B2 (en) 2012-06-13 2018-01-16 Atrium Medical Corporation Cured oil-hydrogel biomaterial compositions for controlled drug delivery
GB201304662D0 (en) 2013-03-14 2013-05-01 Sigmoid Pharma Ltd Compositions
EA036036B1 (ru) * 2014-11-07 2020-09-16 Сигмойд Фарма Лимитед Композиции, содержащие циклоспорин

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI65914C (fi) * 1978-03-07 1984-08-10 Sandoz Ag Foerfarande foer framstaellning av farmaceutiska kompositionerinnehaollande cyklosporin a
SE457693B (sv) * 1986-07-01 1989-01-23 Drilletten Ab Komposition med reglerad frigoering vari ett biologiskt material aer loest eller dispergerat i en l2-fas
GB9113872D0 (en) * 1991-06-27 1991-08-14 Sandoz Ag Improvements in or relating to organic compounds

Also Published As

Publication number Publication date
EP0873133B1 (de) 2002-03-06
ES2123477T3 (es) 2002-08-01
SE9502472L (sv) 1997-01-07
CA2226219A1 (en) 1997-01-23
CZ1998A3 (cs) 1998-06-17
EP0873133A1 (de) 1998-10-28
DE69619700D1 (de) 2002-04-11
BR9609332A (pt) 1999-05-25
SE504582C2 (sv) 1997-03-10
ES2123477T1 (es) 1999-01-16
AU6374596A (en) 1997-02-05
DE69619700T2 (de) 2002-10-24
WO1997002042A1 (en) 1997-01-23
NO980032D0 (no) 1998-01-05
NO980032L (no) 1998-03-03
JPH11508592A (ja) 1999-07-27
DE873133T1 (de) 1999-05-06
SE9502472D0 (sv) 1995-07-06

Similar Documents

Publication Publication Date Title
ATE213951T1 (de) Cyclosporin enthaltende, biologisch aktive zubereitung
CA2221096A1 (en) Skin permeation enhancer compositions comprising glycerol monolaurate and lauryl acetate
ES2088160T3 (es) Formulacion y proceso quimicos.
CA2283280A1 (en) Reovirus for the treatment of neoplasia
TNSN98229A1 (fr) Formulation pharmaceutique orale a liberation prolongee
SE8007639L (sv) Nya tabletter for upplosning i tjocktarmen samt sett for framstellning derav
NO975218L (no) Behandling av inflammatorisk tarmsykdom ved bruk av orale doseringsformer av omega-3-polyumettede syrer
EP0983994A3 (de) Dimethyl-(3-aryl-but-3-enyl)-aminverbindungen als pharmazeutische Wirkstoffe
KR860000865A (ko) 약제 제형의 제조방법
ATE38227T1 (de) Pharmakologisch aktive derivate von pyrido(1,5)benzodiazepinon.
ATE290386T1 (de) Verfahren zur herstellung von di-beta-d- glucopyranosylamin-verbindungen zur regulierung von entzündungsprozessen
NO20035434D0 (no) Behandling eller profylakse av transplantasjonsavst degree tning av insulinproduserende celler
CA2384448A1 (en) Method of treatment of seborrheic dermatitis
Emami et al. Histamine and VIP interactions with receptor-cyclic AMP systems in the human gastric cancer cell line HGT-1
ATE291929T1 (de) Zusammensetzungen zur abgabe von biologischen wirkstoffen und verfahren zu ihrer herstellung
EP0255028A3 (de) Neue 1,4-Benzodiazepine, ihre Herstellung und Verwendung als PAF Antagonisten
YU49404B (sh) Nova smesa koja sadrži ciklosporin i poboljšani postupak za dobijanje mekih želatinskih kapsula koje sadrže ciklosporin
IE36563L (en) Triazolo benzodiazepines
JPS6429317A (en) Local administration composition for treating fungal infection
EA200100366A1 (ru) Антагонист хемокинового рецептора и циклоспорин в комбинированной терапии
JPS5668619A (en) Nifedipine-containing solid composition
JPS5354866A (en) Method of treating sewege
WO1998029131A3 (en) Aqueous glycerol formulations of somatotropin
JPS52125629A (en) Deodorant made from spent sludge from microbial waste-water treatment and method of making the same
FR2754824B1 (fr) Nouvelle composition contenant du chitosan

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties